-
4-{[(3R)-3-(dimethylamino)pyrrolidin-1-yl]methyl}-N-(4-methyl-3-{[4-(pyrimidin-5-yl)pyrimidin-2-yl]amino}phenyl)-3-(trifluoromethyl)benzamide
-
ChemBase ID:
161102
-
Molecular Formular:
C30H31F3N8O
-
Molecular Mass:
576.6153496
-
Monoisotopic Mass:
576.25729231
-
SMILES and InChIs
SMILES:
c1cnc(nc1c1cncnc1)Nc1c(ccc(c1)NC(=O)c1cc(c(cc1)CN1C[C@@H](CC1)N(C)C)C(F)(F)F)C
Canonical SMILES:
CN([C@@H]1CCN(C1)Cc1ccc(cc1C(F)(F)F)C(=O)Nc1ccc(c(c1)Nc1nccc(n1)c1cncnc1)C)C
InChI:
InChI=1S/C30H31F3N8O/c1-19-4-7-23(13-27(19)39-29-36-10-8-26(38-29)22-14-34-18-35-15-22)37-28(42)20-5-6-21(25(12-20)30(31,32)33)16-41-11-9-24(17-41)40(2)3/h4-8,10,12-15,18,24H,9,11,16-17H2,1-3H3,(H,37,42)(H,36,38,39)/t24-/m1/s1
InChIKey:
ZGBAJMQHJDFTQJ-XMMPIXPASA-N
-
Cite this record
CBID:161102 http://www.chembase.cn/molecule-161102.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
4-{[(3R)-3-(dimethylamino)pyrrolidin-1-yl]methyl}-N-(4-methyl-3-{[4-(pyrimidin-5-yl)pyrimidin-2-yl]amino}phenyl)-3-(trifluoromethyl)benzamide
|
|
|
IUPAC Traditional name
|
4-{[(3R)-3-(dimethylamino)pyrrolidin-1-yl]methyl}-N-(4-methyl-3-{[4-(pyrimidin-5-yl)pyrimidin-2-yl]amino}phenyl)-3-(trifluoromethyl)benzamide
|
|
|
Synonyms
|
N-[3-([4,5'-Bipyrimidin]-2-ylamino)-4-methylphenyl]-4-[[(3S)-3-(dimethylamino)-1-pyrrolidinyl]methyl]-3-(trifluoromethyl)benzamide
|
INNO 406
|
NS 187
|
Bafetinib
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
Data Source
|
Data ID
|
Price
|
TRC
|
|
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
12.337041
|
H Acceptors
|
8
|
H Donor
|
2
|
LogD (pH = 5.5)
|
1.275333
|
LogD (pH = 7.4)
|
2.6107388
|
Log P
|
4.66941
|
Molar Refractivity
|
158.2598 cm3
|
Polarizability
|
58.95202 Å3
|
Polar Surface Area
|
99.17 Å2
|
Rotatable Bonds
|
9
|
Lipinski's Rule of Five
|
false
|
DETAILS
DETAILS
TRC
Toronto Research Chemicals -
B109050
|
A substituted benzamide derivative structurally related to STI-571 (Imatinib Mesylate). It was identified as highly potent Bcr-Abl kinase inhibitor. |
REFERENCES
REFERENCES
From Suppliers
Google Scholar
PubMed
Google Books
- • Li, Q., et al.: J. Med. Chem., 39, 3070 (1996)
- • Ptasznik, A., et al.: Nat. Med., 10, 1187 (1996)
- • Tetsuo, A., et al.: Bioorg. Med. Chem. Lett., 16, 1421 (1996)
- Searching...Please wait...
PATENTS
PATENTS
PubChem Patent
Google Patent